针对精神分裂症阴性症状的元认知训练(MCT-Minus):一项实用性随机对照试验的研究方案
主要结局为阴性症状量表(CAINS)评分变化,将在基线、干预后、12周及12个月随访评估,并探索元认知与内化污名等机制。
要点
- MCT-Minus针对精神分裂症阴性症状,此前试点研究显示可减轻症状。
- 主要结局采用CAINS评估阴性症状变化,随访至12个月。
- 研究将探索元认知与内化污名作为潜在变化机制。
核心结论
- 该研究方案旨在评估MCT-Minus相比支持性咨询对精神分裂症阴性症状的疗效,并探索潜在变化机制。
研究设计与样本
- 参与者随机分配至MCT-Minus干预组或支持性咨询对照组,在基线、干预后、12周和12个月随访收集数据。
- 基线和干预后实施磁共振成像(MRI),干预结束后进行退出访谈。
关键数值与推荐
- 主要结局为CAINS测量的阴性症状在所有时间点的变化,采用重复测量ANCOVA评估。
- 额外分析将评估阳性症状变化及元认知和内化污名等潜在机制。
- 退出访谈的定性数据采用反思性主题分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Negative symptoms are experienced by up to 60% of the individuals with schizophrenia and represent a stronger indicator of current and future functioning than positive symptoms. These symptoms respond poorly to pharmacological and existing psychosocial interventions, highlighting the need for targeted treatments. Previous research suggests that defeatist performance beliefs, combined with metacognitive deficits, may contribute to negative symptoms. A recent pilot study, adapting the cognitive intervention metacognitive training (MCT) to address negative symptoms, found symptom reduction, primarily due to improved reflective functioning and reduced perceived stigma. The current study aims to further assess the efficacy of this intervention and to explore potential mechanisms of change in negative symptoms. METHODS: Ninety participants aged 18 and older with a psychotic disorder will be recruited from psychiatric care settings in Sweden. Participants will be randomly assigned to either the intervention group (MCT-Minus) or a control group receiving supportive counselling (SC). Data will be collected at baseline, post-intervention, and at 12-week and 12-month follow-ups. Magnetic resonance imaging (MRI) will be performed at baseline and post-intervention. Exit interviews will be held after completing the intervention. The primary outcome is change in negative symptom, measured by the Clinical Assessment Interview for Negative Symptoms (CAINS), across all time points. Repeated measures ANCOVA will be used to evaluate primary outcomes. Additional analyses will address changes in positive symptoms and potential mechanisms of change, including metacognition and internalized stigma. Qualitative data from exit interviews will be analyzed using reflexive thematic analysis. DISCUSSION: This study is designed to evaluate the efficacy of MCT-Minus compared to supportive counselling. Given the limited treatment options for negative symptoms in schizophrenia, the findings may have important clinical implications. TRIAL REGISTRATION: This study was registered on the 6th of November 2023 on Clinical Trials with the trial registration number NCT06127004. Statistical analyses will be preregistered on the Open Science Framework.
引用
- Swanson L, Rask B, Persson J, et al. Metacognitive Training for Negative Symptoms (MCT-Minus) in schizophrenia: study protocol for a pragmatic randomized controlled trial. Trials. 2026. PMID: 42665851. doi:10.1186/s13063-026-09879-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。